The goal of this study is to determine the safety and efficacy of the administration of vitamin E, which has been shown to delay the progression of Alzheimer's disease, in slowing the rate of cognitive/functional decline in older persons with Down syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Brief Praxis Test, measuring cognitive functions expressed as performances of simple, short, sequences of voluntary movements
Timeframe: Screening, Baseline, every 6 months for 36 months